IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

Press releases published on July 21, 2026

Ferroglobe PLC Schedules Second Quarter 2026 Earnings Call for August 5, 2026
Logistics Division Hyper-Growth (+80% CAGR) Unlocks Multi-Year Run Rate — Accelerating CLIK’s High-Margin Care U Expansion & Strategic Spin-Off
Rezolve Ai Brings Agentic Commerce Infrastructure to Zilch’s Payments Platform Serving Nearly 6 Million Customers
Genius Group Launches Full AI-Powered Product Suite, Building on 147% Year-on-Year Revenue Growth in H1 2026.
Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel
Vaxart to Participate in BTIG Biotechnology Conference 2026
Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
ZenaTech's ZenaDrone Subsidiary Begins Scheduling U.S. Government Defense Demonstrations, Starting with First Confirmed Agency Engagement
Correction: Agentic Day Lands in Toronto, Completing a Three-Country, Two-Continent 2026 Series
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
Arq Schedules Second Quarter 2026 Earnings Conference Call
Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026
Chicago Atlantic Real Estate Finance Schedules Second Quarter 2026 Earnings Release and Conference Call Date
Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

IT Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.